Rheolytic Thrombectomy for DVT a popliteal sheath and was advanced across the thrombus over a 0.018-inch guide wire. Thrombectomy was performed from the proximal edge of the thrombus to the distal edge of the thrombus. During thrombus aspiration, the saline was delivered at an injection rate of 3.5 ml/s and an injection pressure of 850 psi. Aspiration was performed until the throm- Values are mean ± SD or n (%). IVC, inferior vena cava; PTE, pulmonary thromboembolism. bus had disappeared. The extent of thrombus aspiration was assessed using a scoring system based on pre-and post-treatment venography. 4 All venographic images were examined, and the score was calculated independently by two trained observers who were unaware of the clinical data. The score was calculated for 9 venous segments of the upper, middle, and lower IVC, the common iliac vein, the external iliac vein, the common femoral vein, the proximal and distal portions of the superficial femoral vein, and the popliteal vein. The score was classified into 7 categories according to the extent and form of the thrombus: 0: no thrombus; 1: thrombus extends 1/3 of the length of the venous segment without occlusion; 2: thrombus extends 2/3 of the length of the venous segment without occlusion; 3: thrombus extends the entire length of the venous segment without occlusion; 4: thrombus extends 1/3 of the length of the venous segment with occlusion; 5: thrombus extends 2/3 of the length of the venous segment with occlusion; 6: thrombus extends the entire length of the venous segment with occlusion. The total scores for before and after treatment were then calculated by adding all the scores for the 9 venous segments. The difference between the pre-and post-treatment score divided by the pre-treatment score and then multiplied by 100 was classified as the rheolytic rate (ie, the percentage thrombus aspiration achieved) (Figure 1) . Moreover, we evaluated whether there were differences in age, aspiration time, D-dimer concentration on the day of rheolytic thrombectomy, or the duration from onset to therapy between the high rheolytic rate group and the low rheolytic rate group. Written informed consent was given by each enrolled patient.
Statistical Analysis
Statistical analysis was performed with StatView (Version 5.0). Continuous variables are reported as mean ± SD. Comparisons between the high rheolytic rate group and the low rate rheolytic group were performed using the Mann-Whitney test. Comparisons between the pre-and post-treatment venous scores were performed using the paired t-test.
Results
In total, 13 limbs of 13 patients (6 males, 7 females; mean age 50.5±12.2 years) with proximal DVT were treated with rheolytic thrombectomy. The baseline clinical characteristics of the patients are shown in Table 1 . All lesions were totally occluded. Left limbs were more frequently involved than right limbs. The proximal edge of the thrombus was most frequently located in the common iliac vein. The mean duration from onset to rheolytic therapy was 10.2±9.3 days (range: 3-33 days). Five patients had a pulmonary thromboembolus (PTE) detected by lung scan, multidetector computed tomography, and/or pulmonary angiography. The treatment regimen is shown in Table 2 . The mean number of thrombus aspirations was 4.5±1.5. The mean total venographic segment (VS) score before rheolytic thrombectomy was 28.8±7.9 points, and that after rheolytic thrombectomy was 10.4±7.1 points. The total VS score after thrombectomy was significantly lower that before thrombectomy (P<0.0001, Figure 2 ). The mean rheolytic rate (percentage thrombus aspiration achieved) was 61±28%. A low rheolytic rate (<60%) occurred in 4 patients. The mean duration from onset to rheolytic therapy in those 4 patients was 13.5±13.2 days, which was much longer than for the 9 patients with a high rheolytic rate (mean duration: 4.0±2.2 days: P=0.045). However, there were no significant differences in age, sex, Ddimer concentration, number of thrombus aspirations, or pretreatment VS scores ( Table 3) . The mean hemoglobin concentration after rheolytic thrombectomy was 9.9±1.9 g/dl, which was significantly lower than that before thrombec- Rheolytic Thrombectomy for DVT tomy (10.8±1.9 g/dl, P<0.05); however, blood transfusion was not required by any of the patients. One patient suffered a vessel injury caused by a guide wire, but the extravascular bleeding from the left superficial vein stopped immediately and did not result in anemia. Additional interventions for residual thrombi and venous stenosis were performed in 12 patients ( Table 2) : 6 patients were treated with CDT therapy alone and the other 6 were treated with CDT + balloon angioplasty (n=3) or CDT + balloon angioplasty+metallic stenting (n=3). Finally, 9 patients underwent recanalization, and the vessels of 4 patients were occluded despite additional interventions (n=3). IVC filters were not retrieved in 3 patients because of poor prognosis (n=2) or a large residual thrombus (n=1). We could evaluate leg symptoms in the chronic phase in 10 of the 13 patients. The other patients could not be evaluated because of poor prognosis (n=2) or transfer to another hospital (n=1). Leg symptoms were evaluated using the advanced CEAP classification. 5 Mean follow-up was 33.4±24.7 months (range: 5-76 months). During follow-up, none of the patients had chest symptoms that were suspicious for PTE. Seven patients had no leg symptoms (C0), but 3 patients had leg symptoms (1 case was classified as C2, 2 cases were classified as C3). In 2 cases, failure of recanalization resulted in a C3 classification. In 9 of 10 patients, we could evaluate residual DVT and the resultant obstruction with duplex ultrasonography (n=6), venography (n=2), and magnetic resonance venography (n=1). DVT and obstruction were detected in only 2 patients, who had C3 symptoms during the follow-up.
Discussion
Venous thromboembolism remains an important cause of morbidity in Japan. 6,7 Proximal DVT is often associated with acute pulmonary embolism (PE). 6,8,9 Anticoagulation is the standard therapy and is very effective at preventing thrombus progression and PE, 10 but when used as the sole treatment it is less effective at promoting rapid thrombus clearance. 11, 12 Residual thrombi result in venous valvular dysfunction, which consequently causes PTS. Both venous obstruction and valvular reflux are associated with more severe symptoms and PTS. 13, 14 In addition to standard management of DVT with heparin, pharmacological thrombolytic therapy and mechanical thrombectomy have recently been used in patients with acute proximal DVT. 1,2,4 Mechanical thrombectomy has become an important method of managing symptomatic extensive proximal DVT, particularly when used in conjunction with pharmacological thrombolysis. The rheolytic thrombectomy technique is based on the Venturi effect, which is created by high-speed saline jets directed in a retrograde manner. The jets fragment the thrombus and force the resultant thrombus fragments into a catheter. Margheri et al 15 reported the effectiveness and safety of rheolytic thrombectomy for acute PE. In their report, AngioJet rheolytic thrombectomy was used in 25 patients with massive or submassive PE. Technical and procedural success was obtained in all patients, and obstruction, perfusion, and Miller index scores were significantly improved after the procedure.
Kasirajan et al 16 reported the effectiveness and safety of the AngioJet rheolytic thrombectomy as a treatment in 17 patients with extensive DVT; 10 of the 17 patients (59%) demonstrated venographic evidence of >50% thrombus removal and none suffered any complications that were directly related to the use of the AngioJet thrombectomy catheter. Moreover, Kim et al reported that percutaneous CDT combined with rheolytic thrombectomy had a significantly shorter therapy duration and required a lower lytic agent dose than CDT alone. 17 In this study, we report the clinical results of rheolytic thrombectomy as a treatment for proximal DVT and also our evaluation of its efficacy and safety. The mean total VS score of the patients after thrombectomy was significantly decreased compared with that before thrombectomy. Moreover, the mean duration from onset to therapy was significantly shorter in the high rheolytic rate group than in the low rheolytic rate group. However, there were no significant differences in Ddimer concentration, aspiration time, or age between the 2 groups. None of the patients suffered adverse complications. Although anemia progressed, blood transfusion was not necessary in any patient. Additional interventions were performed in most patients (12 of 13 patients; Table 2 ), so rheolytic thrombectomy alone may be insufficient to treat proximal DVT. Kasirajan et al reported that only 4 patients (24%) demonstrated venographic evidence of >90% thrombus clearance after AngioJet rheolytic thrombectomy alone. 16 Thus, combined therapy involving rheolytic thrombectomy and additional interventions (CDT, balloon angioplasty, stenting, etc) may be needed to achieve satisfactory thrombus removal.
We implanted retrieval filters (Günther tulip filters) in all patients; 10 of 13 filters were retrieved (3 filters were left in place because of a residual large thrombus or poor prognosis). A previous report showed that thrombi were trapped in IVC filters in 30% of patients after the initiation of systemic thrombolysis for proximal DVT. 18 Mewissen et al reported that symptomatic PTE occurred in 6 of 287 patients and that 1 patient died during CDT. 19 We used IVC filters to prevent PE, although it is unclear whether it occurred in our series. In addition, the indications for the use of IVC filters during rheolytic thrombectomy are poorly established. In this study, we used Günther tulip filters, and no complications associated with filter use were detected, as shown in a previous report. 20 
Study Limitations
First, the study involved a small retrospective case series and lacked a control group. In addition, the patients were treated with rheolytic thrombectomy at the discretion of the operator, and so operator bias cannot be entirely excluded.
Second, we evaluated the acute phase of rheolytic thrombectomy, and so we were unable to fully evaluate the preservation of venous valve function with Doppler ultrasound or air plethysmography during the chronic phase. It is reported that venous valvular function is better preserved when treated with CDT than when treated with standard anticoagulation. 21 It is unclear whether rheolytic thrombectomy results in a decreased incidence of PTS. Indeed, mechanical thrombectomy itself may damage venous valves.
Finally, we could not evaluate whether rheolytic thrombectomy contributed to reducing the number of additional thrombolytic agents used and/or the treatment time including additional interventions, as reported previously. 21 This is the first study to evaluate the outcome of mechanical thrombectomy in patients with a high rheolytic rate compared with those with a low rheolytic rate. The duration from onset to rheolytic therapy was the only factor that was found to be significantly predictive of the outcome of rheolytic therapy.
Conclusions
This report revealed that rheolytic thrombectomy is safe and effective for treating proximal DVT. In addition, the duration TSUJI A et al. from onset to therapy was the only factor affecting the outcome of rheolytic thrombectomy in this study. Rheolytic thrombectomy was especially effective when it was performed within 1 week of DVT onset.
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